0.5139
price up icon2.15%   0.0108
after-market Dopo l'orario di chiusura: .51 -0.0039 -0.76%
loading

Veru Inc Borsa (VERU) Ultime notizie

pulisher
10:23 AM

Veru signals Q3 2025 regulatory clarity for enobosarm Phase 3 trial - MSN

10:23 AM
pulisher
May 14, 2025

Barclays PLC Acquires 21,738 Shares of Veru Inc. (NASDAQ:VERU) - Defense World

May 14, 2025
pulisher
May 14, 2025

Veru Inc. (NASDAQ:VERU) Stake Raised by Wells Fargo & Company MN - Defense World

May 14, 2025
pulisher
May 12, 2025

Veru (NASDAQ:VERU) Issues Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat

May 12, 2025
pulisher
May 10, 2025

Veru Inc. (NASDAQ:VERU) Q2 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025
pulisher
May 09, 2025

Veru Inc. Reports Progress in Clinical Trials and Financials - TipRanks

May 09, 2025
pulisher
May 09, 2025

Veru Inc (VERU) Q2 2025 Earnings Call Highlights: Promising Clinical Results Amid Financial ... - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Veru Inc (VERU) Q2 2025 Earnings Call Highlights: Promising Clinical Results Amid Financial ... By GuruFocus - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

Veru Inc (VERU) Q2 2025 Earnings Call Highlights: Promising Clinical Results Amid Financial Challenges - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Earnings call transcript: Veru Inc. beats Q2 2025 EPS forecast, stock rises - Investing.com India

May 09, 2025
pulisher
May 09, 2025

Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress - GlobeNewswire

May 09, 2025
pulisher
May 08, 2025

Veru Q2 2025 Earnings Call Transcript - MarketBeat

May 08, 2025
pulisher
May 08, 2025

Veru Inc. (VERU) Advances Obesity Program with Promising Trial Results - GuruFocus

May 08, 2025
pulisher
May 08, 2025

VERU INC. SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 08, 2025

Veru Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025
pulisher
May 08, 2025

Veru Participates in a Virtual Investor KOL Connect Segment | VERU Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

JTC Team Hosts Virtual Investor “KOL Connect” Segment to Discuss Veru Inc.’s (NASDAQ:VERU) Enobosarm Taking GLP-1 Weight Loss to Next Level - Sacramento Bee

May 08, 2025
pulisher
May 08, 2025

JTC Team Hosts Virtual Investor "KOL Connect" Segment to Discuss Veru Inc.'s (NASDAQ:VERU) Enobosarm Taking GLP-1 Weight Loss to Next Level - Mid Florida Newspapers

May 08, 2025
pulisher
May 08, 2025

Veru Participates in a Virtual Investor KOL Connect Segment - GlobeNewswire

May 08, 2025
pulisher
May 08, 2025

2 Beaten-Down Stocks That Are Great Buys on the Dip - The Globe and Mail

May 08, 2025
pulisher
May 08, 2025

Veru Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025 - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Veru Inc (VERU) Reports Q2 Fiscal 2025 EPS of -$0.05, Beating Estimates of -$0.06; Revenue Focus Remains on Clinical Progress - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress | VERU Stock News - GuruFocus

May 08, 2025
pulisher
May 07, 2025

Veru Inc (VERU) Q2 2025 Earnings Report Preview: What To Look For - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Envestnet Asset Management Inc. Buys 75,997 Shares of Veru Inc. (NASDAQ:VERU) - Defense World

May 07, 2025
pulisher
May 07, 2025

Veru (VERU) Projected to Post Earnings on Thursday - MarketBeat

May 07, 2025
pulisher
May 06, 2025

Financial Snapshot: Analyzing Veru Inc (VERU)’s Key Ratio Metrics - DWinneX

May 06, 2025
pulisher
May 06, 2025

Veru Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView

May 06, 2025
pulisher
May 05, 2025

JPMorgan Chase & Co. Has $166,000 Stock Holdings in Veru Inc. (NASDAQ:VERU) - Defense World

May 05, 2025
pulisher
May 05, 2025

Adage Capital Partners GP L.L.C. Sells 5,561,111 Shares of Veru Inc. (NASDAQ:VERU) - MarketBeat

May 05, 2025
pulisher
May 04, 2025

NewEdge Advisors LLC Raises Stock Position in Veru Inc. (NASDAQ:VERU) - Defense World

May 04, 2025
pulisher
May 02, 2025

Check out these key findings about Veru Inc (VERU) - Sete News

May 02, 2025
pulisher
May 01, 2025

Veru Inc (VERU)’s stock price range in the last year - uspostnews.com

May 01, 2025
pulisher
May 01, 2025

Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8 - The Manila Times

May 01, 2025
pulisher
May 01, 2025

Veru Inc. to Host Conference Call for Fiscal Q2 2025 Financial Results and Business Update on May 8, 2025 - Nasdaq

May 01, 2025
pulisher
Apr 30, 2025

B. Riley Securities gives a Buy recommendation for Veru Inc (VERU) - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Veru Inc (VERU) Stock: A Comprehensive 52-Week Review - investchronicle.com

Apr 30, 2025
pulisher
Apr 30, 2025

Geode Capital Management LLC Increases Stock Position in Veru Inc. (NASDAQ:VERU) - Defense World

Apr 30, 2025
pulisher
Apr 28, 2025

ImmunityBio Inc’s Market Journey: Closing Weak at 2.61, Down -2.97 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Trading Day Review: Capri Holdings Ltd (CPRI) Gains Momentum, Closing at 14.87 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Market Momentum: Coherus Biosciences Inc (CHRS) Registers a 1.98 Increase, Closing at 1.03 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Stock Performance Spotlight: Veru Inc (VERU) Ends the Day at 0.54, Down by -2.02 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 28, 2025
pulisher
Apr 26, 2025

Bronstein, Gewirtz & Grossman, LLC Announces Veru Inc. (VERU) Investigation - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 24, 2025

SOBO Shares Experience Surge in Value - knoxdaily.com

Apr 24, 2025
pulisher
Apr 23, 2025

Was Veru Inc (VERU)’s session last reading good? - uspostnews.com

Apr 23, 2025
pulisher
Apr 16, 2025

Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summi - GuruFocus

Apr 16, 2025
$67.22
price up icon 2.45%
$19.65
price up icon 2.99%
$33.12
price up icon 2.57%
$23.09
price up icon 1.49%
$92.34
price up icon 0.28%
biotechnology ONC
$225.77
price up icon 2.65%
Capitalizzazione:     |  Volume (24 ore):